Categories
rss rss-es rss-pt

Update on the Safety of Andexxa by AstraZeneca: FDA Safety Communication

Murilo Freitas - 05:00, 18 de December de 202543
Since approval, the FDA has received postmarketing safety data on thromboembolic events, including serious and fatal outcomes, in patients treated with Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo). Based on available data, the serious risks including the increase in thromboembolic

http://www.fda.gov/safety/medical-product-safety-information/update-safety-andexxa-astrazeneca-fda-safety-communication

 
Categories
rss

Olympus Announces Voluntary Corrective Action for the Single-Use Ligating Device

Murilo Freitas - 05:00, 17 de December de 202547
Center Valley, Pa., (December 5, 2025)-Olympus Corporation today announced a voluntary medical device corrective action for its Single-Use Ligating Device (“Polyloop”) following identification of a potential safety issue.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/olympus-announces-voluntary-corrective-action-single-use-ligating-device

 
PRAIS 2.0